Legal & General Group PLC Gossamer Bio, Inc. Transaction History
Legal & General Group PLC
- $390 Billion
- Q2 2025
A detailed history of Legal & General Group PLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 21,159 shares of GOSS stock, worth $51,204. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,159Holding current value
$51,204% of portfolio
0.0%Shares
17 transactions
Others Institutions Holding GOSS
# of Institutions
147Shares Held
160MCall Options Held
2.89MPut Options Held
130K-
Octagon Capital Advisors LP New York, NY18.4MShares$44.4 Million8.57% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$43.8 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$27.6 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$19.5 Million5.25% of portfolio
-
Acadian Asset Management LLC Boston, MA7.15MShares$17.3 Million0.02% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $227M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...